Inhibitor Therapeutics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2022-03-30
- Inhibitor Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2020 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-26 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 |
| 2014-12-31 | $0.00 10-K · filed 2015-02-13 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |